Nobel Biocare Holdin (NBHGY) Stock Price, News & Analysis

Company Overview

Nobel Biocare Holding AG is a global innovator in digital dentistry, specializing in the development, manufacturing and marketing of dental implant systems and restorative solutions. The company’s core offerings include a comprehensive portfolio of implant designs, prosthetic components and patient-specific solutions, alongside digital treatment planning software. These products are designed to support clinicians in delivering predictable, esthetic and long-term outcomes in dental reconstruction and rehabilitation.

Founded in 1981 and headquartered in Zurich, Switzerland, Nobel Biocare traces its roots to the discovery of osseointegration by Professor Per-Ingvar Brånemark. Since its inception, the company has focused on advancing implant dentistry through continuous research and development, introducing landmark systems such as NobelActive, NobelReplace and All-on-4. The firm also offers digital planning tools—NobelClinician and Procera software—that enable clinicians to simulate and optimize treatment workflows from diagnostics through final restoration.

Nobel Biocare operates in more than 80 countries across Europe, the Americas and Asia Pacific, serving a network of dental professionals, clinics and laboratories. In addition to its product portfolio, Nobel Biocare provides hands-on training programs and clinical support to help practitioners adopt the latest techniques in implant placement and prosthetic design. The company’s global footprint and commitment to innovation have positioned it as a key player in the dental implant market.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 10 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NBHGY
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A